Encompass Health Co. (NYSE:EHC) Shares Acquired by Franklin Resources Inc.

Franklin Resources Inc. grew its holdings in Encompass Health Co. (NYSE:EHCFree Report) by 18.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,265 shares of the company’s stock after purchasing an additional 8,988 shares during the quarter. Franklin Resources Inc. owned approximately 0.06% of Encompass Health worth $3,821,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Benjamin Edwards Inc. lifted its stake in shares of Encompass Health by 3.8% during the fourth quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock valued at $259,000 after buying an additional 142 shares during the period. Treasurer of the State of North Carolina lifted its stake in shares of Encompass Health by 0.5% during the third quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock valued at $3,246,000 after buying an additional 231 shares during the period. Linden Thomas Advisory Services LLC lifted its stake in shares of Encompass Health by 1.7% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 15,473 shares of the company’s stock valued at $1,032,000 after buying an additional 253 shares during the period. Handelsbanken Fonder AB lifted its stake in shares of Encompass Health by 1.9% during the fourth quarter. Handelsbanken Fonder AB now owns 15,953 shares of the company’s stock valued at $1,064,000 after buying an additional 300 shares during the period. Finally, Inceptionr LLC lifted its stake in shares of Encompass Health by 3.5% during the fourth quarter. Inceptionr LLC now owns 9,029 shares of the company’s stock valued at $602,000 after buying an additional 306 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on EHC shares. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Truist Financial increased their price target on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Raymond James reaffirmed a “strong-buy” rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday, April 26th. Barclays increased their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Finally, Mizuho increased their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $92.00.

Check Out Our Latest Stock Analysis on EHC

Encompass Health Stock Performance

Shares of EHC stock opened at $86.39 on Friday. The company’s fifty day simple moving average is $83.02 and its 200-day simple moving average is $74.74. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $87.94. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. The company has a market cap of $8.70 billion, a PE ratio of 23.35, a P/E/G ratio of 1.35 and a beta of 0.92.

Encompass Health (NYSE:EHCGet Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the firm posted $0.88 EPS. The business’s revenue for the quarter was up 13.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.1 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Monday, July 1st. Encompass Health’s payout ratio is 16.22%.

Insider Activity at Encompass Health

In related news, CEO Mark J. Tarr sold 44,976 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the completion of the sale, the chief executive officer now directly owns 554,098 shares of the company’s stock, valued at approximately $46,139,740.46. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction on Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the completion of the sale, the insider now directly owns 18,594 shares of the company’s stock, valued at approximately $1,580,861.88. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Mark J. Tarr sold 44,976 shares of the firm’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the transaction, the chief executive officer now directly owns 554,098 shares of the company’s stock, valued at $46,139,740.46. The disclosure for this sale can be found here. In the last three months, insiders sold 69,519 shares of company stock valued at $5,816,091. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Recommended Stories

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.